Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell broadly Friday, as investors took profits following a flurry of earnings reports, including a blowout quarter from Amazon, and an...
Vaxart stock has gained 54% over the past month as the company continues to press its case for an oral COVID vaccine. Its phase 1 trial results were considered disappointing but Vaxart has issued a robust response. The company is still under investigation for possibly making misle...
Vaxart (VXRT), which is developing an oral COVID-19 vaccine, is up more than 9% to $9.21 in afternoon trading as chatter on the Wall Street Bets Reddit channel heats up and the company announced its founder will present at a major vaccines conference.Sean Tucker, who is also chief s...
SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its founder and chief scientific officer, S...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the stock market today! For investors, an upcoming policy decision from the Federal Reserve is a key factor this morning. Earnings from tech giants like Microsoft (NASDAQ: MSFT ) are also m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the largest roadblocks in the progress toward Covid-19 reopening is the seemingly endless cropping up of new strains. Now, with a coming webinar hosted by Vaxart (NASDAQ: VXRT ), we might be looking at treatmen...
Vaxart ([[VXRT]] +46.5%) shares are on the rise today, and if the rally holds the stock appears to be on course to post its highest one-day gain since early February.So far 150.7M Vaxart shares have changed hands more than 11 times the 65-day average volume at ~13.4M.Despite the resignation o...
Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biotechnology company Vaxart (NASDAQ: VXRT ), as the name implies, is known for developing vaccines. There are other, more famous coronavirus vaccine makers out there, but VXRT stock is cheap and m...
News, Short Squeeze, Breakout and More Instantly...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an underwritten offering of 50,000,000 shares of its common stock at an offering price of $0.80 per share, which is a premium to the last closing price of $0.75 per ...